2 recruiting, 1 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow Vima Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy VIM0423, VIM0423 Placebo - PARKINSON DISEASE (Disorder) | Phase 2 | Recruiting | Vima Therapeutics | 80 | 2026-09-01 | 2026-10-27 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia VIM0423, VIM0423 Placebo - Dystonia | Phase 2 | Recruiting | Vima Therapeutics | 100 | 2026-02-05 | 2026-10-26 |
| An Observational Study of Individuals With Isolated Dystonia Isolated/Primary Dystonia That Affects More Than One Region of the Body | Active not recruiting | Vima Therapeutics | 200 | 2025-06-17 | 2026-09-21 |
Dystonia (2) · Dystonic Disorders (2) · Torticollis (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Parkinson Disease (1) · Parkinsonian Disorders (1) · Tremor (1)
United States (3) · Canada (2)